{"id":"W2093009907","doi":"10.1056/nejmoa1114287","title":"Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1703,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Placebo; Medicine; Multiple sclerosis; Internal medicine; Clinical endpoint; Regimen; Placebo-controlled study; Gastroenterology; Randomized controlled trial; Double blind; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002763854,0.002084157,0.00455808,0.0008037714,0.0008197356,0.0009621625,0.001250533,0.002721252,0.007219355],"category_scores_gemma":[0.001805348,0.0007965956,0.001383598,0.0004707485,0.001419193,0.0008589292,0.0004427675,0.003050978,0.001378078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000620752,"about_ca_system_score_gemma":0.001846625,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008825824,"about_ca_topic_score_gemma":0.001900902,"domain_scores_codex":[0.9990696,0.0004961643,0.00004625088,0.0001396923,0.00009306065,0.000155314],"domain_scores_gemma":[0.9986994,0.0002483889,0.0002329533,0.0001108449,0.000150343,0.0005579542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9579411,0.01981243,0.0004111133,0.0004378232,0.0003797527,0.00004148595,0.00004466921,0.0002513277,0.007301311,0.00005356207,0.0006405386,0.01268499],"study_design_scores_gemma":[0.8440945,0.152999,0.001278272,0.00001989899,0.0001352294,0.00002447387,0.00001047946,0.0002136124,0.0006660479,0.00005574176,0.0004916284,0.0000112244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747385,0.004591111,0.001574433,0.0008057578,0.000690021,0.01387076,0.001548467,0.0004176487,0.001763246],"genre_scores_gemma":[0.9654287,0.002235318,0.004062594,0.001850556,0.0006066673,0.02045625,0.001612525,0.00006479677,0.003682532],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007219355,"threshold_uncertainty_score":0.02415109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1492640750751503,"score_gpt":0.3816020995237962,"score_spread":0.2323380244486459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}